Interestingly, PD-L1+CD36+% and PD-1+CD36+% in newly diagnosed lymphoma subjects were significantly higher than in healthy volunteers (median: 8% vs. 1%; 5 vs. 0.2, P < 0.001) (Table 2). This evidence concerns the gene CD36 and lymphoma.